Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Machine Learning Predictability of Clinical Next Generation Sequencing for Hematologic Malignancies to Guide High-Value Precision Medicine.

AMIA ... Annual Symposium proceedings. AMIA Symposium - 1 Jan 2021

Kim Grace Y E, Noshad Morteza, Stehr Henning, Rojansky Rebecca, Gratzinger Dita, Oak Jean, Brar Rondeep, Iberri David, Kong Christina, Zehnder James, Chen Jonathan H

Abstract excerpt

Advancing diagnostic testing capabilities such as clinical next generation sequencing methods offer the potential to diagnose, risk stratify, and guide specialized treatment, but must be balanced against the escalating costs of healthcare to identify patient cases most likely to benefit from them. Heme-STAMP (Stanford Actionable Mutation Panel for Hematopoietic and Lymphoid Malignancies) is one such next...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematologic Neoplasms
Share to Heme

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Machine Learning

Share to Mutation

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 35308914
PMCID: PMC8861666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Machine Learning Predictability of Clinical Next Generation Sequencing for Hematologic Malignancies to Guide High-Value Precision Medicine.PMID 35308914Read ↗

Using Artificial Intelligence (AI) to Model Clinical Variant Reporting for Next Generation Sequencing (NGS) Oncology AssaysSemantic proximity Read ↗

From Genomics to AI: Revolutionizing Precision Medicine in OncologySemantic proximity Read ↗

Azurify integrates cancer genomics with machine learning to classify the clinical significance of somatic variantsSemantic proximity Read ↗

An artificial intelligence-based model for prediction of Clonal Hematopoiesis mutants in cell-free DNA samplesSemantic proximity Read ↗

An artificial intelligence-based model for prediction of clonal hematopoiesis variants in cell-free DNA samplesSemantic proximity Read ↗

A deep learning solution to predict tumor mutational status : an evaluation as a first-line diagnostic toolSemantic proximity Read ↗

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.Semantic proximity Read ↗

Predicting clinical outcomes from large scale cancer genomic profiles with deep survival modelsSemantic proximity Read ↗

Predicting Survivability of Cancer Patients with Metastatic Patterns Using Explainable AISemantic proximity Read ↗

Evaluating the Predictability of Cancer Types from 536 Somatic Mutations: A New Dataset.Semantic proximity Read ↗

Using Machine Learning to Identify True Somatic Variants from Next-Generation SequencingSemantic proximity Read ↗

Fragmentomic-based algorithm to computationally predict tumor-somatic, germline, and clonal hematopoiesis variant origin in liquid biopsySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.